Atlas Trials

Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects

Clinical trial NCT00966602 · COMPLETED

Trial details

NCT number
NCT00966602
Sponsor
Vertex Pharmaceuticals Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2009-09-01
Primary completion
2009-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.